Greenhawt M (2016) Food allergy quality of life and living with food allergy. Curr Opin Allergy Clin Immunol 16(3):284–290

Article  CAS  PubMed  Google Scholar 

Cummings AJ, Knibb RC, King RM, Lucas JS (2010) The psychological impact of food allergy and food hypersensitivity in children, adolescents and their families: a review. Allergy 65:933–945

Article  CAS  PubMed  Google Scholar 

Allen CW, Bidarkar MS, vanNunen SA, Campbell DE (2015) Factors impacting parental burden in food allergic children. J Paediatr Child Health 51:696–698

Article  PubMed  Google Scholar 

Gupta R, Holdford D, Bilaver L, Dyer A, Holl JL, Meltzer D (2013) The economic impact of childhood food allergy in the United States. JAMA Pediatr 167:1026–1031

Article  PubMed  Google Scholar 

Warren CM, Otto AK, Walkner MM, Gupta RS (2016) Quality of life among food allergic patients and their caregivers. Curr Allergy Asthma Rep 16:38

Article  PubMed  Google Scholar 

Levy MB, Elizur A, Goldberg MR, Nachshon L, Katz Y (2014) Clinical predictors for favorable outcomes in an oral immunotherapy program for IgE-mediated cow’s milk allergy. Ann Allergy Asthma Immunol 112(1):58-63.e1

Article  CAS  PubMed  Google Scholar 

Goldberg MR, Nachshon L, Appel MY, Elizur A, Levy MB, Eisenberg E et al (2015) Efficacy of baked milk oral immunotherapy in baked milk-reactive allergic patients. J Allergy Clin Immunol 136(6):1601–1606

Article  CAS  PubMed  Google Scholar 

Wood RA, Kim JS, Lindblad R, Nadeau K, Henning AK, Dawson P et al (2016) A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow’s milk allergy. J Allergy Clin Immunol 137(4):1103–1110.e11. https://doi.org/10.1016/j.jaci.2015.10.005. Epub 2015 Nov 12. PMID: 26581915; PMCID: PMC5395304

Vickery BP, Vereda A, Casale TB, Beyer K, Du Toit G, Hourihane JO et al (2018) AR101 Oral immunotherapy for peanut allergy. N Engl J Med 397:1991–2001

Google Scholar 

Nachshon L, Goldberg MR, Levy MB, Appel MY, Epstein-Rigbi N, Lidholm J et al (2019) Efficacy and safety of sesame oral immunotherapy-a real-world, single-center study. J Allergy Clin Immunol Pract 7(8):2775-2781.e2 PMID: 31150789

Article  PubMed  Google Scholar 

Burks AW, Jones SM, Wood RA, Fleischer DM, Sicherer SH, Lindblad RW et al (2012) Consortium of Food Allergy Research (CoFAR). Oral immunotherapy for treatment of egg allergy in children. N Engl J Med 367(3):233–43. PMID: 22808958; PMCID: PMC3424505

Jones SM, Burks AW, Keet C, Vickery BP, Scurlock AM, Wood RA et al (2016) Long-term treatment with egg oral immunotherapy enhances sustained unresponsiveness that persists after cessation of therapy. J Allergy Clin Immunol 137(4):1117–1127.e10

Kim EH, Perry TT, Wood RA, Leung DYM, Berin MC, Burks AW et al (2020) Consortium for Food Allergy Research (CoFAR). Induction of sustained unresponsiveness after egg oral immunotherapy compared to baked egg therapy in children with egg allergy. J Allergy Clin Immunol 146(4):851–862.e10

Elizur A, Appel MY, Nachshon L, Levy MB, Epstein-Rigbi N, Golobov K et al (2018) NUT Co Reactivity - ACquiring Knowledge for Elimination Recommendations (NUT CRACKER) study. Allergy 73(3):593–601. https://doi.org/10.1111/all.13353. Epub 2017 Dec 5 PMID: 29127694

Article  CAS  PubMed  Google Scholar 

Elizur A, Appel MY, Nachshon L, Levy MB, Epstein-Rigbi N, Pontoppidan B et al (2019) Walnut oral immunotherapy for desensitisation of walnut and additional treenut allergies (Nut CRACKER): a single-centre, prospective cohort study. Lancet Child Adolesc Health 3(5):312–321. https://doi.org/10.1016/S2352-4642(19)30029-X. Epub 2019 Mar 27. Erratum in: Lancet Child Adolesc Health 3(7):e10. PMID: 30926371

Elizur A, Appel MY, Nachshon L, Levy MB, Epstein-Rigbi N, Koren Y et al (2022) Cashew oral immunotherapy for desensitizing cashew-pistachio allergy (NUT CRACKER study). Allergy. https://doi.org/10.1111/all.15212. Epub ahead of print. PMID: 35000223

Pajno GB, Fernandez-Rivas M, Arasi S, Roberts G, Akdis CA, Alvaro- Lozano M et al (2018) EAACI guidelines on allergen immunotherapy: IgE-mediated food allergy. Allergy 73:799–815

Article  CAS  PubMed  Google Scholar 

Bégin P, Chan ES, Kim H, Wagner M, Cellier MS, Favron-Godbout C et al (2020) CSACI guidelines for the ethical, evidence-based and patient-oriented clinical practice of oral immunotherapy in IgE-mediated food allergy. Allergy Asthma Clin Immunol 16:20

Article  PubMed  PubMed Central  Google Scholar 

Martorell A, Alonso E, Echeverría L, Escudero C, García-Rodríguez R, Blasco C et al (2017) Immunotherapy egg and milk Spanish guide (ITEMS guide). Part I: cow milk and Egg oral immunotherapy: introduction, methodology, rationale, current state, indications, contraindications, and oral immunotherapy build-up phase. J Investig Allergol Clin Immunol 27(4):225–237

Pajno GB, Bernardini R, Peroni D, Arasi S, Martelli A, Landi M et al (2017) Allergen-specific Immunotherapy panel of the Italian Society of Pediatric Allergy and Immunology (SIAIP). Clinical practice recommendations for allergen-specific immunotherapy in children: the Italian consensus report. Ital J Pediatr 43(1):13

Ebisawa M, Ito K, Fujisawa T (2020) Committee for Japanese Pediatric Guideline for Food Allergy, The Japanese Society of Pediatric Allergy and Clinical Immunology; Japanese Society of Allergology. Japanese guidelines for food allergy 2020. Allergol Int 69(3):370–386

Nachshon L, Goldberg MR, Katz Y, Levy MB, Elizur A (2018) Long-term outcome of peanut oral immunotherapy – real life experience. Pediatr Allergy Immunol 29(5):519–526

Article  PubMed  Google Scholar 

Epstein-Rigbi N, Goldberg MR, Levy MB, Nachshon L, Elizur A (2019) Quality of life of food-allergic patients before, during, and after oral immunotherapy. J Allergy Clin Immunol Pract 7(2):429-436.e2. https://doi.org/10.1016/j.jaip.2018.06.016. Epub 2018 Jul 7 PMID: 30129441

Article  PubMed  Google Scholar 

Epstein-Rigbi N, Goldberg MR, Levy MB, Nachshon L, Elizur A (2020) Quality of life of children aged 8–12 years undergoing food allergy oral immunotherapy: child and parent perspective. Allergy 75(10):2623–2632 PMID: 32350869

Article  PubMed  Google Scholar 

Otani IM et al (2014) Multiple-allergen oral immunotherapy improves quality of life in caregivers of food-allergic pediatric subjects. Allergy Asthma Clin Immunol 10:25

Article  PubMed  PubMed Central  Google Scholar 

Chu DK, Wood RA, French S, Fiocchi A, Jordana M, Waserman S et al (2019) Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety. Lancet 393(10187):2222–2232. https://doi.org/10.1016/S0140-6736(19)30420-9. Epub 2019 Apr 25. Erratum in: Lancet. 2019;393(10184):1936. PMID: 31030987

Eiwegger T, Anagnostou K, Arasi S, Bégin P, Ben-Shoshan M, Beyer K et al (2019) ICER report for peanut OIT comes up short. Ann Allergy Asthma Immunol 123(5):430–432. https://doi.org/10.1016/j.anai.2019.09.001. Epub 2019 Sep 9 PMID: 31513908

Article  PubMed  PubMed Central  Google Scholar 

Nachshon L, Goldberg MR, Elizur A, Levy MB, Schwartz N, Katz Y (2015) A web site-based reporting system for monitoring home treatment during oral immunotherapy for food allergy. Ann Allergy Asthma Immunol 114(6):510–515. https://doi.org/10.1016/j.anai.2015.04.007. Epub 2015 May 1 PMID: 25940735

Article  PubMed  Google Scholar 

Petroni D, Spergel JM (2018) Eosinophilic esophagitis and symptoms possibly related to eosinophilic esophagitis in oral immunotherapy. Ann Allergy Asthma Immunol 120(3):237–240.e4..2017.11.016

Nachshon L, Schwartz N, Tsviban L, Levy MB, Goldberg MR, Epstein-Rigby N et al (2021) Patient characteristics and risk factors for home epinephrine-treated reactions during oral immunotherapy for food allergy. J Allergy Clin Immunol Pract 9(1):185-192.e3 Epub 2020 Aug 1 PMID: 32750430

Article  CAS  PubMed  Google Scholar 

Nachshon L, Levy MB, Goldberg MR, Epstein-Rigbi N, Schwartz N, Katz Y et al (2022) Triggers for home epinephrine-treated reactions during oral immunotherapy for food allergy. J Allergy Clin Immunol Pract S2213–2198(21):01450–01451 PMID: 34982978

Google Scholar 

Shaker MS, Wallace DV, Golden DBK, Oppenheimer J, Bernstein JA, Campbell RL et al (2020) Anaphylaxis-a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis. J Allergy Clin Immunol 145(4):1082–1123

Article  CAS  PubMed  Google Scholar 

Muraro A, Werfel T, Hoffmann-Sommergruber K, Roberts G, Beyer K, Bindslev-Jensen C et al (2014) EAACI food allergy and anaphylaxis guidelines group. EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy. Allergy 69(8):1008–25. https://doi.org/10.1111/all.12429

Cardona V, Ansotegui IJ, Ebisawa M, El-Gamal Y, Fernandez Rivas M, Fineman S et al (2020) World allergy organization anaphylaxis guidance 2020. World Allergy Organ J 13(10):100472. https://doi.org/10.1016/j.waojou.2020.100472. PMID: 33204386; PMCID: PMC7607509

Article  PubMed  PubMed Central  Google Scholar 

Young VB (2017) Effective management of pain and anxiety for the pediatric patient in the emergency department. Crit Care Nurs Clin North Am 29(2):205–216. https://doi.org/10.1016/j.cnc.2017.01.007. Epub 2017 Mar 18 PMID: 28460701

Article  PubMed  Google Scholar 

Lemos L, Assis HC, Alves JL, Reis DS, Campos Canesso MC et al (2022) Neuroimmune circuits involved in β-lactoglobulin-induced food allergy. Brain Behav Immun Health 21(23):100471 PMID: 35668724

Article  Google Scholar 

Florsheim EB, Bachtel ND, Cullen J, Lima BGC, Godazgar M, Zhang C et al (2023) Immune sensing of food allergens promotes aversive behaviour. bioRxiv [Preprint]. 2023 Jan 20:2023.01.19.524823. https://doi.org/10.1101/2023.01.19.524823. Update in: Nature. PMID: 36712030; PMCID: PMC9882358

Goldberg MR, Elizur A, Nachshon L, Appel MY, Levy MB, Golobov K et al (2017) Oral immunotherapy-induced gastrointestinal symptoms and peripheral blood eosinophil responses. J Allergy Clin Immunol 139(4):1388-1390.e4. https://doi.org/10.1016/j.jaci.2016.09.053. Epub 2016 Nov 29 PMID: 27913305

Article  PubMed  Google Scholar 

• Wright BL, Fernandez-Becker NQ, Kambham N, Purington N, Cao S, Tupa D et al (2021) Gastrointestinal eosinophil responses in a longitudinal, randomized trial of peanut oral immunotherapy. Clin Gastroenterol Hepatol 19(6):1151–1159.e14. https://doi.org/10.1016/j.cgh.2020.05.019. PMID: 32434067; PMCID: PMC8445108. Baseline esophageal eosinophilia was noted in some subjects that increased during OIT, albeit it did not correlate with symptoms.

Underwood B, Troutman TD, Schwartz JT (2023) Breaking down the complex pathophysiology of eosinophilic esophagitis. Ann Allergy Asthma Immunol 130(1):28–39. https://doi.org/10.1016/j.anai.2022.10.026. Epub 2022 Nov 6. PMID: 36351516

• Goldberg MR, Nachshon L, Levy MB, Elizur A, Katz Y (2020) Risk Factors and Treatment Outcomes for Oral Immunotherapy-Induced Gastrointestinal Symptoms and Eosinophilic Responses (OITIGER). J Allergy Clin Immunol Pract 8(1):125–131. https://doi.org/10.1016/j.jaip.2019.07.034. Epub 2019 Aug 2. PMID: 31382040. Treatment by decreasing dose and/or rate of allergen progression during OIT, alleviated non-anaphylactic symptoms and blood eosinophils normalized to baseline.

Stein ML, Levy MM, Goldberg MR et al (2012) Classification, prevalence and outcomes of non-IgE mediated reactions to oral food immunotherapy. J Allergy Clin Immunol 129:AB29

Wasserman RL, Hague AR, Pence DM et al (2019) Real-world experience with peanut oral immunotherapy: lessons learned From 270 patients. J Allergy Clin Immunol Pract 7(2):418-426.e4. https://doi.org/10.1016/j.jaip.2018.05.023

Article  PubMed  Google Scholar 

•• Epstein-Rigbi N, Elizur A, Levy MB, Nachshon L, Koren Y, Shalem Z et al (2023) Treatment of oral immunotherapy-associated eosinophilic esophagitis. J Allergy Clin Immunol Pract 11(4):1303–1305.e2. https://doi.org/10.1016/j.jaip.2022.11.010. OIT-associated EoE can be successfully treated with PPI and/or SWCS without having to discontinue treatment.

Echeverria-Zudaire LA, Fernandez-Fernandez S, Rayo-Fernandez A, Munoz-Archidona C, Checa-Rodriguez R (2016) Primary eosinophilic gastrointestinal disorders in children who have received food oral immunotherapy. Allergol Immunopathol (Madr) 44:531–536

Article  CAS  PubMed  Google Scholar 

Capucilli P, Hill DA (2019) Allergic comorbidity in eosinophilic esophagitis: mechanistic relevance and clinical implications. Clin Rev Allergy Immunol 57(1):111–127. https://doi.org/10.1007/s12016-019-08733-0. PMID: 30903437; PMCID: PMC6626558

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hamant L, Freeman C, Garg S, Wright BL, Schroeder S (2021) Eosinophilic esophagitis may persist after discontinuation of oral immunotherapy. Ann Allergy Asthma Immunol 126(3):299–302. https://doi.org/10.1016/j.anai.2020.12.007. Epub 2020 Dec 17. PMID: 33340664; PMCID: PMC7897277

Lucendo AJ, Arias A, Tenias JM (2014) Relation between eosinophilic esophagitis and oral immunotherapy for food allergy: a systematic review with meta-analysis. Ann Allergy Asthma Immunol 113:624–629 ([PubMed: 25216976])

Article  PubMed  Google Scholar 

Sanchez-Garcia S, Rodriguez Del Rio P, Escudero C, Martinez-Gomez MJ, Ibanez MD (2012) Possible eosinophilic esophagitis induced by milk oral immunotherapy. J Allergy Clin Immunol 129:1155–1157 ([PubMed: 22236725])

Article  PubMed  Google Scholar 

Burk CM, Dellon ES, Steele PH, Virkud YV, Kulis M, Burks AW, Vickery BP (2017) Eosinophilic esophagitis during peanut oral immunotherapy with omalizumab. J Allergy Clin Immunol Pract 5:489–501 ([PubMed: 27843067])

Article